Doctor profile · Federal record
Dr. Charles Croft, MD, FACP, FACC
Interventional Cardiology Physician (CMS: Cardiovascular Disease (Cardiology)) · Cardiovascular Disease Physician · Melbourne, FL
- NPI 1043296783
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 53 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1402 Oak St
Melbourne, FL 329013113
(321) 722-3288
fax (321) 722-3468 - Additional location
-
1324 Valentine St
Melbourne, FL 329013128
Credentials & registration
- NPI registered
- December 2005 — 21 yrs on file
- Profile last updated
- October 2, 2025
- Year of graduation
- 1973 — 53 yrs since
- Specialty taxonomy
- 207RI0011X — NUCC code
- State license (1)
- Florida #ME46400
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1043296783. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,644
Distinct HCPCS
10
Medicare allowed
$865,904
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 2,448 | 53 | $1 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,410 | 925 | $14 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,230 | 740 | $125 | |
G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 445 | 54 | $35 | |
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 427 | 278 | $8 | |
99152 |
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 341 | 322 | $13 | |
93297 |
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 339 | 41 | $26 | |
A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose | 330 | 165 | $110 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 325 | 151 | $79 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 319 | 100 | $21 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 215. This provider delivers 54× the peer median.Open Payments
Industry payments received
All-time total
$1,933
Transactions
56
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ShockWave Medical, Inc | 3 | $459.46 | |
| Novartis Pharmaceuticals Corporation | 13 | $188.80 | |
| Abbott Laboratories | 3 | $159.24 | |
| ABIOMED | 5 | $139.96 | |
| PFIZER INC. | 9 | $133.47 | |
| Biosense Webster, Inc. | 1 | $113.23 | |
| Novo Nordisk Inc | 1 | $110.79 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $80.75 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69.35 | |
| Janssen Pharmaceuticals, Inc | 3 | $60.97 | |
| Medtronic, Inc. | 3 | $60.80 | |
| Kestra Medical Technology Services, Inc. | 2 | $54.33 | |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48.08 | |
| Daiichi Sankyo Inc. | 2 | $46.76 | |
| Lexicon Pharmaceuticals, Inc. | 2 | $43.58 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,119
Patients
1,386
Total drug cost
$1,150,792
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 468 | 151 | $10,497 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 386 | 147 | $5,764 |
| Eliquis (Apixaban) | Brand | 360 | 98 | $411,443 |
| Entresto (Sacubitril/Valsartan) | Brand | 343 | 90 | $423,346 |
| Furosemide | Generic | 324 | 110 | $1,658 |
| Nifedipine Er (Nifedipine) | Brand | 316 | 107 | $15,140 |
| Metoprolol Tartrate | Generic | 314 | 111 | $2,193 |
| Atorvastatin Calcium | Generic | 296 | 89 | $5,120 |
| Xarelto (Rivaroxaban) | Brand | 230 | 59 | $260,408 |
| Nitroglycerin | Generic | 202 | 123 | $4,142 |
Hospital affiliations
Frequently asked questions
What is Dr. Charles Croft's medical specialty?
Dr. Charles Croft practices Interventional Cardiology Physician in Melbourne, FL.
Where does Dr. Charles Croft practice?
Dr. Charles Croft practices at 1402 Oak St, Melbourne, FL 329013113. Office phone: 3217223288.
What is Dr. Charles Croft's NPI?
Dr. Charles Croft's National Provider Identifier (NPI) is 1043296783, issued by NPPES.
Does Dr. Charles Croft accept Medicare assignment?
Yes. Dr. Charles Croft accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Charles Croft commonly perform?
Top Medicare-reported procedures in 2023: Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) (HCPCS J0153); Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS 93000); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.